LRPPRC deficiency drives cuproptosis evasion via metabolic reprogramming and dysregulated copper homeostasis in RCC bone metastasis
Bone metastasis poses a significant clinical challenge and remains a major threat to survival in patients with advanced renal cell carcinoma (RCC), and current treatments often fail because metastatic bone lesions are inherently resistant to conventional bone-targeted drugs. Cuproptosis, a recently described copper...